2/25
12:30 am
tndm
Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032
Low
Report
Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032
2/23
04:05 pm
tndm
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
Low
Report
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
2/23
12:05 pm
tndm
Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition [Seeking Alpha]
Medium
Report
Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition [Seeking Alpha]
2/23
08:59 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its "hold" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $27.00 price target on the stock, up previously from $24.00.
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its "hold" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $27.00 price target on the stock, up previously from $24.00.
2/23
08:03 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) was upgraded by analysts at Lake Street Capital from a "hold" rating to a "buy" rating.
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) was upgraded by analysts at Lake Street Capital from a "hold" rating to a "buy" rating.
2/23
07:17 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
2/23
07:01 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/20
10:01 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) was given a new $22.00 price target on by analysts at Mizuho.
Medium
Report
Tandem Diabetes Care (NASDAQ:TNDM) was given a new $22.00 price target on by analysts at Mizuho.
2/20
09:36 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its price target raised by analysts at Stifel Nicolaus from $20.00 to $22.00. They now have a "hold" rating on the stock.
Medium
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its price target raised by analysts at Stifel Nicolaus from $20.00 to $22.00. They now have a "hold" rating on the stock.
2/20
08:06 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
2/20
08:03 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) was upgraded by analysts at Bank of America Corporation from an "underperform" rating to a "neutral" rating. They now have a $30.00 price target on the stock, up previously from $15.00.
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) was upgraded by analysts at Bank of America Corporation from an "underperform" rating to a "neutral" rating. They now have a $30.00 price target on the stock, up previously from $15.00.
2/20
07:18 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at Piper Sandler.
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at Piper Sandler.
2/20
12:16 am
tndm
Tandem Diabetes Care Inc (TNDM) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]
High
Report
Tandem Diabetes Care Inc (TNDM) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]
2/19
11:21 pm
tndm
Tandem Diabetes Care Q4 Earnings Call Highlights [Yahoo! Finance]
High
Report
Tandem Diabetes Care Q4 Earnings Call Highlights [Yahoo! Finance]
2/19
04:05 pm
tndm
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance
High
Report
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance
2/12
04:05 pm
tndm
Tandem Diabetes Care Announces Upcoming Conference Presentations
Low
Report
Tandem Diabetes Care Announces Upcoming Conference Presentations
2/11
04:07 pm
tndm
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Medium
Report
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
2/8
12:23 pm
tndm
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Low
Report
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
2/7
06:30 am
tndm
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
Low
Report
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
2/5
08:24 pm
tndm
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Low
Report
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
2/4
08:59 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its price target raised by analysts at Stifel Nicolaus from $16.00 to $20.00. They now have a "hold" rating on the stock.
Low
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its price target raised by analysts at Stifel Nicolaus from $16.00 to $20.00. They now have a "hold" rating on the stock.
2/3
05:56 am
tndm
1 Small-Cap Stock with Exciting Potential and 2 Facing Headwinds [Yahoo! Finance]
Medium
Report
1 Small-Cap Stock with Exciting Potential and 2 Facing Headwinds [Yahoo! Finance]
2/2
04:09 pm
tndm
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Medium
Report
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
2/2
01:33 am
tndm
Is Tandem Diabetes Care (TNDM) Starting To Look Attractive After Prolonged Share Price Weakness? [Yahoo! Finance]
Low
Report
Is Tandem Diabetes Care (TNDM) Starting To Look Attractive After Prolonged Share Price Weakness? [Yahoo! Finance]
1/31
01:31 pm
tndm
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
Low
Report
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM